You are here: Industry Insights > BTG

News List

Bridging the Gaps Eases COVID Safety Protocols and Expands In-Person Services prnewswire
May 28, 2021
After more than a year of adhering to strict safety measures to help tamp down the spread of the virus, BTG is finally able to ease some of its protocols and restart services that that were temporarily restricted or delivered virtually.
Boston Scientific considers sale of speciality pharmaceutical unit pharmaceutical-technology
July 16, 2020
Boston Scientific is considering the divestiture of its speciality pharmaceutical business, focused on snake venom treatments, reported Bloomberg citing people familiar with the matter.
Boston Scientific Closes Acquisition of BTG americanpharmaceuticalreview
August 20, 2019
Boston Scientific Corporation has announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in ...
BTG chief Dame Louise Makin in line for £20m windfall after firm's sale dailymail
November 26, 2018
The woman who turned BTG into a diverse pharmaceuticals and life sciences company could bank up to £20million from its takeover.....
Carrick licenses targeted ovarian cancer drug from BTG pharmatimes
October 12, 2018
Dublin, Ireland-based biopharma Carrick Therapeutics has licensed exclusive globl rights to develop and commercialise BTG’s targeted ovarian cancer drug BTG945.
Carrick bags ex-Onyx cancer drug, plans pivotal trials fiercebiotech
October 12, 2018
Carrick revealed details of the licensing agreement alongside news that it has appointed George Golumbeski as chairman.
BTG buys Irish med device group Novate pharmatimes
September 13, 2018
Specialist healthcare group BTG has snapped up med tech group Novate Medical in a deal potentially worth $150 million.